特定于RLIM的活动报告员在Tonne-Kalscheuer综合征中定义了变异性致病性
Venkateshwarlu Bandi1, Martin Rennie2, Intisar Koch1
1Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.
HGG advances
|November 1, 2024
概括
托恩-卡尔施尔综合征 (TOKAS) 研究人员开发了流细胞计报告器来测量RLIM基因活性. 这些测试有助于确定TOKAS变异的致病性,加速诊断和理解这种罕见的遗传疾病.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 托恩-卡尔施尔综合征 (TOKAS) 是一种X关联疾病,导致智力障碍和先天性异常.
- 托卡斯与RLIM基因的变异有关,该基因编码了一个关键的E3泛酸酶.
- 越来越多的不确定的RLIM变异需要强大的病原性查方法.
研究的目的:
- 设计和验证RLIM特定的报告员测试以测量RLIM活动.
- 使用这些测试来确定特定的TOKAS相关RLIM变异 (p.Asn581Lys) 的致病性.
- 阐明p.Asn581Lys变种的功能影响和潜在的致病机制.
主要方法:
- 开发基于流细胞计的报告系统,使用全长RLIM或其基底REX1降解区域.
- 工程RLIM报告器的应用,以评估细胞模型中的RLIM活动.
- 使用开发的报告测试,对TOKAS变异RLIM p.Asn581Lys的表征.
主要成果:
- 特定于RLIM的流细胞计报告器成功测量了细胞中的RLIM活性.
- 发现TOKAS变异RLIM p.Asn581Lys会破坏RLIM的催化活性.
- 这项研究提供了关于p.Asn581Lys变种如何损害RLIM功能的见解,这表明了病原性途径.
结论:
- 特定于RLIM的流细胞计报告器是评估RLIM活性和变体致病性的有效工具.
- 在TOKAS患者中发现的p.Asn581Lys变异会损害RLIM功能,从而导致疾病的发病.
- 这些报告员测定将大大加快不确定的RLIM变体的分类和它们与TOKAS的关联.
相关概念视频
Translation
14.6K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.6K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K


